Facts
The assessee, M/s. Cadila Health Care, formed a 50:50 Joint Venture (JV), 'Sarabhai Zydus Animal Health Ltd.', and transferred 22 veterinary trademarks/brand names "along with goodwill of the business" for Rs. 29.10 crores via a Deed of Assignment dated 15.06.2000
Source reference: p. 3, 17The assessee claimed this was a capital receipt not chargeable to tax for AY 2001-02, as the trademarks were self-generated assets with no determinable cost of acquisition
Source reference: p. 3The Assessing Officer (AO) disagreed, treating the amount as business income under Section 28(iv) or Section 41(1), or alternatively as capital gains by applying the 2001 amendment to Section 55(2)(a) retrospectively
Source reference: p. 4, 33The ITAT ruled in favor of the assessee
Source reference: p. 1, 4Issues
Whether the consideration of Rs. 29.10 crores received for assignment of self-generated trademarks was liable to tax as capital gains for AY 2001-02
Source reference: p. 2; para. 10Whether the Finance Act 2001 amendment to Section 55(2)(a), which defined the cost of acquisition of trademarks as 'Nil', has retrospective effect
Source reference: p. 9-10; para. 15Whether the ITAT was right in allowing a short-term capital loss of Rs. 2,50,45,545 as claimed by the assessee
Source reference: p. 2; para. 26Law Applied
The court primarily applied the principle from *CIT v. B.C. Srinivasa Shetty [1981] 128 ITR 294 (SC)*, which holds that if the cost of acquisition of a self-generated asset cannot be conceived/determined, the computation provisions of Section 48 fail, and capital gains cannot be charged under Section 45
Source reference: p. 5, 19-21It applied Section 55(2)(a) of the Income Tax Act, 1961, noting that the inclusion of "trademark or brand name" was only introduced by the Finance Act, 2001, w.e.f. 01.04.2002
Source reference: p. 22-23, 31-32Regarding the short-term capital loss, the court followed *CIT v. Walfort Share and Stock Brokers Pvt. Ltd. [2010] 326 ITR 1 (SC)*
Source reference: p. 17, 38Reasoning
The Court observed that for an asset to be taxed under "Capital Gains," a cost of acquisition must be identifiable to satisfy the computation mechanism under Section 48
Source reference: p. 20, 31Prior to the Finance Act 2001 amendment (effective AY 2002-03), self-generated trademarks had no statutory "Nil" cost
Source reference: p. 22Following *Fernhill Laboratories (Bom HC)* and *Vatika Township (SC)*, the Court held that the amendment to Section 55(2)(a) is prospective and cannot apply to the relevant AY 2001-02
Source reference: p. 14, 23It rejected the Revenue’s argument that the transfer constituted "goodwill of business" because the assessee only transferred its Veterinary Division's trademarks and retained its primary pharmaceutical business; goodwill cannot exist independently of the business
Source reference: p. 29-30Furthermore, the receipt could not be taxed under Section 28(iv) (business perquisites) or Section 41(1) (remission of liability) because a capital sale of an intangible asset does not constitute a "benefit arising from business" in the sense of a perquisite
Source reference: p. 33-34Holding
The High Court answered all issues in favor of the assessee and against the Revenue
It held that the consideration for assignment of self-generated trademarks is not taxable as capital gains for AY 2001-02 as the cost of acquisition was then indeterminable
Source reference: para. 23, 25The Court confirmed that the 2001 amendment to Section 55(2)(a) is prospective
Source reference: para. 19The short-term capital loss was allowed following the *Walfort Share* precedent
Source reference: para. 26The appeals were dismissed
Source reference: para. 27Original Court PDF
The Commissioner of Income Tax, Ahmedabad-I v. Zydus Lifesciences Limited (Formerly Cadila Health Care) [R/Tax Appeal No. 1234 of 2007 with R/Tax Appeal No. 1235 of 2007]
Click to open original judgment
Original judgment, available to read, download and summarize on LawLens.in